To our knowledge, this is the first study in the literature evaluating HLA-B subtypes in cases developing TB while using anti-TNF agents and comparing with the HLA-B subtypes of three different groups including community-acquired TB cases, anti-TNF patients without TB and healthy controls. This evidence concerns the gene TNF and tuberculosis.